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Abstract
State health departments in Michigan, Minnesota, Oregon, and Utah explored the use of genomic information, 
including family health history, in chronic disease prevention programs. To support these explorations, the Office of 
Public Health Genomics at the Centers for Disease Control and Prevention provided cooperative agreement funds from 
2003 through 2008. The 4 states’ chronic disease programs identified advocates, formed partnerships, and assessed 
public data; they integrated genomics into existing state plans for genetics and chronic disease prevention; they 
developed projects focused on prevention of asthma, cancer, cardiovascular disease, diabetes, and other chronic 
conditions; and they created educational curricula and materials for health workers, policymakers, and the public. 
Each state’s program was different because of the need to adapt to existing culture, infrastructure, and resources, yet 
all were able to enhance their chronic disease prevention programs with the use of family health history, a low-tech 
“genomic tool.” Additional states are drawing on the experience of these 4 states to develop their own approaches.
Background
The Human Genome Project concluded in 2003, attracting attention to genomic research as a source for health 
information and applications (1). State public health departments already had well-established programs to screen 
newborns for rare genetic disorders, provide clinical genetic services to underserved populations, and conduct 
surveillance for birth defects and developmental disabilities. State programs for chronic disease prevention and health 
promotion were focused on monitoring health problems, promoting healthful behaviors, and assuring access to 
preventive services. Using genomic information in these programs was largely uncharted territory (2).
To explore the potential use of genomic information in chronic disease prevention, the Centers for Disease Control and 
Prevention supported pilot programs in 4 states from 2003 through 2008. We describe the strategies, successes, 
challenges, and consequences of these programs, which offer potential models for using genomic information —
particularly family health history — for public health action.
Methods
Cooperative agreements
The Chronic Disease Directors’ Summit in 2002 called on CDC to help states respond to knowledge and applications 
emerging from the Human Genome Project (3). In 2003, CDC announced the availability of funding for public health 
genomics through a cooperative agreement with CDC’s National Center for Chronic Disease Prevention and Health 
Promotion (4). The same funding announcement also included 6 other components of chronic disease prevention: 
tobacco; nutrition, physical activity, and obesity; Well-Integrated Screening and Evaluation for Women Across the 
Nation (WISEWOMAN); oral health; arthritis; and the Behavioral Risk Factor Surveillance System. The intent of this 
bundled announcement was to encourage collaboration among programs on common objectives and cross-cutting risk 
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factors. State health departments and other eligible organizations could apply for funds for any or all components 
listed in the announcement through a competitive process. Box 1 lists cooperative agreement activities for public 
health genomics.
State strategies
From 2003 through 2008, four states — Michigan, 
Minnesota, Oregon, and Utah — received cooperative 
agreement funds for public health genomics. Annual 
awards between $150,000 and $250,000 allowed each 
state to support 1 full-time staff member. Additional 
staff were hired part-time or as student interns; health 
departments also contributed staff time in kind (eg, for 
health education or web development support). States 
submitted annual progress reports to CDC.
Michigan, Oregon, and Utah chose to expand their 
existing state genetics plans, developed in 2002 with 
support from the Health Resources and Services 
Administration. They enhanced these plans with 
specific goals and activities that emphasized the role of 
genomics in chronic disease prevention programs (5–
7). For example, new objectives in the Utah plan 
included educating health care providers and the public 
on genetic screening and testing; collecting and using 
family history in disease prevention; assessing the role 
of genetics in chronic disease clusters; developing a 
statewide family history database; and addressing state 
policy and ethical issues (8). Minnesota made a 
strategic decision to integrate genetic risk factors and 
strategies into state plans for preventing chronic 
diseases.
All 4 states integrated genomic information —
particularly family health history — into prevention 
plans for 1 or more chronic diseases, including asthma, obesity and diabetes, heart disease, and stroke. The most 
detailed plans focused on cancer. Oregon’s comprehensive cancer control plan added an objective to increase 
awareness of cancer family history as a factor in individual cancer risk (9). Minnesota’s plan added objectives to 
promote appropriate referral and third-party payment for genetic risk assessment for cancer (10).
Findings
Some key accomplishments are summarized in the following sections, corresponding with the categories in Box 1. 
References to published and online materials provide additional examples, details, and background information.
Developing leadership capacity
Project staff in the 4 funded states identified “champions,” leaders within the health department who helped to develop 
partnerships and advisory groups. These groups varied in composition and scope, with members coming from various 
types of organizations: government agencies, academic and research institutions, health care plans, community 
groups, private businesses, genealogy organizations, and other entities. Oregon convened a broad Genetic Advisory 
Committee with clinical, public health, and academic members to gather input for Oregon’s Strategic Plan for Genetics 
and Public Health (6). Michigan formed the Michigan Cancer Genetics Alliance to promote translation of cancer 
genetics research into clinical and public health practice for cancer detection, prevention, and treatment (11). Utah’s 
Family Health History Taskforce provided leadership for public awareness, clinical applications, and methodology and 
research related to family health history (12). Minnesota developed a partnership with the Center for Public Health 
Education and Outreach at the University of Minnesota.
Incorporating genomics into population-based assessments and surveillance
All 4 states had access to population-based data collected by state surveillance systems. Michigan, Oregon, and Utah 
added state-specific questions to the BRFSS (topics covered are listed in Table 1). Results of these surveys described 
the influence of family health history on respondents’ perceived risk, behaviors, health care experiences, and 
awareness of genetic tests marketed directly to the public (13–18). Utah used the Youth Risk Behavior Surveillance 
System (YRBSS) to assess high school students’ knowledge of genetics and found that black, Native American, and 
Box 1. Program Activities 
Supported by Cooperative 
Agreements in Public Health 
Genomics Through the Centers for 
Disease Control and Prevention, 
2003–2008
• Develop or expand leadership capacity in public 
health genomics.
• Develop and implement population-based 
assessments and incorporate genomics into disease-
specific data collection through surveillance and 
registries.
• Implement or expand the use of genomics in 
program activities.
• Educate the health care workforce, policy makers, 
and the public about the importance and role of 
family health history and genetic risk factors in 
disease etiology and prevention.
• Prepare the chronic disease workforce for using 
genomic tools to reduce the burden of specific 
diseases, and teach them the benefits and limitations 
of genetic tests.
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Pacific Islander students were less likely than others to report having received lessons on family health history (8, pp. 
31–36). Oregon added questions on family health history to the Pregnancy Risk Assessment and Monitoring System 
(PRAMS) and the General Knowledge Survey (19). The Oregon Health Authority compiled an online summary of data 
from surveys conducted in the 4 pilot states and other state surveillance systems during 2001 through 2010 (20).
The Michigan public health genomics program collaborated with the Michigan Cancer Surveillance Program (MCSP), 
the state’s cancer registry, to assess completeness of cancer family history in oncology patients’ charts. They found that 
more than 80% of 853 charts documented the presence or absence of a family history of cancer and the tumor site; 
however, fewer than 10% included age at cancer diagnosis, a key indicator for assessing potential genetic risk (21). On 
the basis of these findings, MCSP in 2007 began requiring that case reports include family history data, making it 
possible to ascertain cancer patients at high risk for familial cancer.
Michigan also developed a novel, population-based surveillance system for sudden cardiac death among the young 
(SCDY). Michigan used these data to bring attention to SCDY as a public health problem, identifying an underlying 
genetic cause in a large proportion of cases (22,23).
Using genomic information in disease prevention programs
State programs used population-based data to inform educational activities, policies, and standards for using family 
health history to enhance early disease detection and prevention (Table 2). Michigan and Minnesota integrated family 
history risk assessments and educational materials into the screening process for WISEWOMAN programs (24). The 
success of these efforts helped to establish family history risk assessment as a service component of subsequent 
WISEWOMAN grants.
Michigan integrated family history questions into the baseline participant survey of its Healthy Homes University 
program. This program is funded by the US Department of Housing and Urban Development (DHUD) to reduce 
asthma triggers in low- to moderate-income households that include a child with asthma. Sixty-five percent of children 
with diagnosed asthma in Michigan’s survey had at least 1 first-degree relative with asthma. By identifying affected 
relatives, Michigan’s program was able to offer education and products to reduce asthma triggers to 150 additional 
persons with asthma in 92 of the first 162 households enrolled in the project (25). This innovative approach was 
recognized by DHUD and has been sustained in Michigan (26). Utah also addressed asthma prevention, analyzing 
BRFSS data for asthma family history and conducting asthma genomics workshops in 2006 and 2007.
From 2006 through 2009, the Michigan Colorectal Cancer Screening Program offered colorectal cancer screening to 
asymptomatic low-income, uninsured, and underinsured persons in 3 counties with high colorectal cancer mortality 
rates. The program linked local health departments with genetics services and provided data for use in communicating 
with program participants. Of the approximately 1,500 adults screened, 177 were referred to a genetic counselor. In 
Minnesota, the Department of Health integrated family history educational materials into the Sage Screening Program 
for breast and cervical cancer among underserved women aged 40 or older (27).
The Oregon public health genomics program focused on policy development, supporting the legislatively established 
Advisory Committee on Genetic Privacy and Research and facilitating a new Genetics Advisory Committee that served 
the Oregon Health Services Commission and Oregon’s Medicaid program. In 2007, the commission approved all of the 
committee’s recommendations on coverage of genetic services under Oregon’s Medicaid program. These services 
included testing for the BRCA1 or BRCA2mutation in patients without cancer who met US Task Force on Preventive 
Services guidelines as well as genetic testing for Lynch syndrome according to National Comprehensive Cancer 
Network guidelines. The Oregon public health genomics program analyzed state legislation, drafted testimony, and 
provided information on legislative issues, such as the development of an Oregon Birth Defects Registry, the 
disclosures permitted by the Oregon Genetic Privacy Act, and the use of genetic information in criminal cases (28).
Educating the health workforce, policy makers, and the public
To increase awareness and understanding of the use of genomics — particularly family health history — in disease 
prevention, the states provided courses, seminars, and lectures and developed educational materials for public health 
practitioners, health care providers, policy makers, teachers, students, and the public (Table 2). To train state public 
health practitioners working in cancer control and prevention, Michigan produced a seminar series titled Cancer 
Genomics for Public Health. Oregon hosted a brown bag series on genomics for state public health workers, and 
Minnesota collaborated with the University of Minnesota’s School of Public Health to organize courses on genomics for 
the university’s annual Summer Public Health Institutes. Minnesota conferences on genomics in 2004 and 2005 
attracted more than 200 participants.
Michigan developed continuing education modules on genomics, family history, and diabetes, which were accessed by 
more than 300 health care providers. Michigan also helped create a core lecture for first-year medical students at 
Wayne State University and collaborated with a regional health care network in southeastern Michigan to establish an 
annual grand rounds lecture on genomics for physicians and medical residents. Oregon explained how to use family 
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history to identify patients at high risk for diabetes, colorectal cancer, breast cancer, and hyperlipidemia in CD 
Summary, a bi-weekly publication distributed to approximately 18,000 persons, including all licensed health care 
professionals in Oregon (29).
Michigan developed the Genetics to Genomics Workshop, which enrolled approximately 200 secondary school 
teachers in 2005 through 2006. Utah partnered with the University of Utah’s Genetic Science Learning Center to 
establish the Community Genetics Education Network, which provides genetic education to underserved and 
underrepresented minority communities. Utah developed and field tested the curriculum Using Family History to 
Improve Your Health to teach high school students about hereditary, lifestyle, and environmental components of 
chronic disease and to help them understand disease risk. The curriculum met national and state health education and 
biology standards and was made available in Spanish.
For health care providers and the public, Minnesota developed and broadly disseminated fact sheets on family history 
of chronic diseases. Utah developed the Family History Toolkit to help people collect and interpret their family health 
history (30). The English version of the tool kit was downloaded from the Utah website more than 75,000 times, the 
Spanish version nearly 20,000 times, and a version for seniors more than 11,000 times. All 4 states also promoted 
public awareness of family health history with media activities each November, when the US Surgeon General 
encourages Americans to discuss family health history as part of the Thanksgiving Day observance. For their efforts, 
Utah received the 2006 Silver Award for Excellence in Public Health Communication from the National Public Health 
Information Coalition.
Effect of Early Pilot Efforts
Four state health departments developed pilot programs that integrated human genomics into core public health 
functions and programs. They were encouraged to explore local opportunities and build on existing resources, an 
approach that yielded novel projects that were difficult to evaluate as a whole. Nevertheless, they achieved important 
successes in 3 major areas: 1) conducting population-based assessments and surveillance to develop evidence for the 
use of genomic information and family history in state disease prevention efforts; 2) demonstrating the integration of 
this information into existing disease prevention programs, such as WISEWOMAN and Healthy Homes University; 
and 3) developing, disseminating, and documenting the uptake of educational materials for the health workforce, 
policy makers, and the public.
The pilot programs also delivered some useful lessons on strategies and challenges for integrating genomics into public 
health programs for chronic disease prevention (Box 2) (31). Perhaps most important, they showed that there is no 
single model for success; rather, approaches must be adapted to state culture, infrastructure, and resources. The 
support of health department leadership, when available, proved to be crucial. Opportunities to promote the 
development of genomics activities within other state and local health department programs helped leverage resources 
and integrate genomics into practice. External partnerships were also important; in addition to other state agencies 
and universities, these sometimes included nontraditional partners such as genealogy groups, businesses, and news 
media. Features that helped sustain some activities beyond the end of the cooperative agreement period included 
relevance to existing programs, need for no more than incremental changes, visibility, and demonstrated effect. Key 
challenges included the scarcity of actionable evidence, competing priorities, scarce financial and personnel resources, 
and communication barriers between public health and genetics professionals.
Although the pilot programs did not set out to measure 
health outcomes, they created a foundation for 
successes in subsequent years. Michigan and Oregon 
sustained their public health genomics programs with 
limited state funding and in 2008 received new, 3-year 
cooperative agreements for implementing evidence-
based recommendations on hereditary cancer through 
education, surveillance, and policy development. The 
new programs built on infrastructure developed during 
the pilot programs to carry out targeted interventions. 
Michigan used cancer registry data from 2006 through 
2007 to identify more than 15,000 people needing 
evaluation for BRCA1 or BRCA2 or Lynch syndrome by 
the end of 2012. The Michigan Public Health Genomics 
Program and the MCSP established a bidirectional 
reporting system, which returns information on 
persons with characteristics suggesting hereditary 
cancer to the 150 health care institutions that report to 
the MCSP (32). In addition, the state partnered with 
Box 2. Integrating Genomics into 
Public Health Chronic Disease 
Prevention Programs: Successful 
Strategies and Challenges
Successful strategies
• Obtain support of health department leadership 
and decision makers.
• Seek partnership with early adopters of genomics 
among disease prevention programs.
• Meet programs at their level of interest in a way 
that is flexible, responsive, and open to ideas.
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payers to extend insurance coverage for these services 
to over 7 million Michigan residents (33).
The experiences of Michigan, Minnesota, Oregon, and 
Utah are useful to a growing number of states —
including Connecticut, Ohio, and Georgia — that are 
developing their own approaches (34–36). 
Expectations for genomic medicine have moderated 
considerably during the last decade, but evidence-based 
recommendations now support the use of several 
genomic health applications to prevent chronic diseases 
(37). In particular, nearly 2 million Americans are at 
increased risk for early-onset cancer or heart disease 
because they have a hereditary breast or ovarian cancer 
mutation (BRCA1 or BRCA2), Lynch syndrome, or 
familial hypercholesterolemia; most people with these 
conditions are not aware they have them, yet early 
detection and intervention could save their lives (38).
CDC’s Office of Public Health Genomics website offers 
materials for implementing interventions that proceed 
from evidence-based recommendations (39). Many of 
these are products of the pilot programs described in 
this article. They show how to build partnerships 
between public health and private health care, enhance 
cancer registry reporting for selected hereditary 
cancers, develop coverage for recommended clinical 
services, devise surveillance indicators for tracking 
health impact, and deliver information to health care 
providers, policy makers, and the public.
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Tables
Table 1. Genomic Information Collected by the Behavioral Risk Factor 
Surveillance System (BRFSS), by State, 2003–2008
Information Category
2003 2004 2005 2006 2007 2008
OR MI MN OR MI OR UT MI OR UT MI OR UT MI OR UT
Family history prevalence
Asthma — — — — — — — — — X — — — — — —
Breast or ovarian cancer — — — — — — — X — — — — — X — —
Cardiovascular disease — — — — — — — — — — X X — — — —
Colorectal cancer — — — — X — — — — — — — — — X —
Diabetes X — X X — X — — X — — — X — — X
Chronic disease (general) — — — — — — X — — X — — X — — X
Awareness and collection of family 
health history
— X — — X — X — — X — X X — — X
Awareness and use of DTC genetic 
testing
— — — — — — — X — X — X X — X X
Opinions on the use of dried blood 
spots in research
— — — — — — — — — — — — — X — —
Abbreviations: OR, Oregon; MI, Michigan; MN, Minnesota; UT, Utah; —, data not collected; DTC, direct-to-consumer.
State participation in BRFSS and survey questions varied by year.
Table 2. Selected Highlights, Public Health Genomics Programs by State, 
2003–2008
Topic Area Michigan Minnesota Oregon Utah
Disease-specific 
prevention plans and 
programs
• Asthma
• Cancer
• CVD
• Obesity
• Asthma
• Cancer
• CVD
• Diabetes
• Disabilities
• Cancer
• CVD
• Diabetes
• Nutrition and 
physical fitness
• Asthma
• Cancer
• CVD
Policies, guidelines, 
and standards • Cancer registry
• Electronic health 
record
• WISEWOMAN
• WISEWOMAN • Privacy
• Health plan
• Birth defects 
registry
• Medical family 
history
Education and training
• Public health 
workers
• Secondary 
teachers
• Health 
professionals
• Public health 
workers
• Graduate 
students
• Health 
professionals
• Public health 
workers
• Health 
professionals
• Public health 
workers
• Underserved 
communities
• Health 
professionals
a
a
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